|
C18ORF19 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.860300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.237400E-01 |
| Normal-vs-Stage2 |
2.288800E-01 |
| Normal-vs-Stage3 |
6.461500E-03 |
| Normal-vs-Stage4 |
1.67226999999714E-05 |
| Stage1-vs-Stage2 |
2.198300E-02 |
| Stage1-vs-Stage3 |
2.828500E-02 |
| Stage1-vs-Stage4 |
5.71630000000267E-05 |
| Stage2-vs-Stage3 |
3.151000E-04 |
| Stage2-vs-Stage4 |
4.00860000004943E-06 |
| Stage3-vs-Stage4 |
6.817600E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.976130E-02 |
| Normal-vs-AfricanAmerican |
2.846600E-01 |
| Normal-vs-Asian |
1.804390E-01 |
| Caucasian-vs-AfricanAmerican |
7.833400E-01 |
| Caucasian-vs-Asian |
7.593000E-01 |
| AfricanAmerican-vs-Asian |
9.693000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.279900E-02 |
| Normal-vs-Female |
8.599600E-02 |
| Male-vs-Female |
6.262000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.926600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.613870E-02 |
| Normal-vs-Age(61-80Yrs) |
1.957800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.311000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.552300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.213800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.168800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.644400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.275000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.626600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.283800E-03 |
| Classical-VS-Follicular |
1.213050E-01 |
| Classical-VS-Other |
4.950000E-01 |
| Classical-VS-Normal |
1.468400E-01 |
| Tall-VS-Follicular |
5.69649999999644E-05 |
| Tall-VS-Other |
3.249400E-01 |
| Tall-VS-Normal |
5.650299999993E-05 |
| Follicular-VS-Other |
2.602000E-01 |
| Follicular-VS-Normal |
9.488200E-01 |
| Other-VS-Normal |
1.663960E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.290800E-01 |
| Normal-vs-N1 |
8.969700E-04 |
| N0-vs-N1 |
8.619700E-03 |
|
|
